Mye-InfoBank Publications
Signoretto I, Calzetti F, Finotti G, Lonardi S, Balanzin C, Bianchetto-Aguilera F, Gasperini S, Gardiman E, Castellucci M, Russignan A, Bonifacio M, Sica A, Vermi W, Tecchio C, Scapini P, Tamassia N, Cassatella MA. Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis. Cell Mol Immunol. 2025 Feb 13. doi: 10.1038/s41423-025-01259-w. Epub ahead of print. PMID: 39939817
Lin C, Kuzmanović A, Wang N, Liao L, Ernst S, Penners C, Jans A, Hammoor T, Stach P B, Peltzer M, Volkert I, Zechendorf E, Hassan R, Myllys M, Liedtke C, Herrmann A, Chakraborty G, Trautwein C, Hengstler J, Müller-Newen G, Wang J, Ghallab A, Bartneck M. Exceptional Uptake, Limited Protein Expression: Liver Macrophages Lost in Translation of Synthetic mRNA. Adv Sci 2025, 2409729. doi: 10.1002/advs.202409729
Glaría E, Martínez PR, Font-Díaz J, De la Rosa JV, Castrillo A, Crawshaw DJ, Vidal Taboada JM, Saura J, Matalonga J, Nunes Chini E, Caelles C, Valledor AF. Liver X Receptors and Inflammatory-Induced C/EBPβ Selectively Cooperate to Control CD38 Transcription. J Innate Immun. 2025;17(1):56-77. doi: 10.1159/000543274. Epub 2024 Dec 19. PMID: 39701049; PMCID: PMC11781815
Reste M, Ajazi K, Sayi-Yazgan A, Jankovic R, Bufan B, Brandau S, Bækkevold ES, Petitprez F, Lindstedt M, Adema GJ, Almeida CR. The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases. Front. Immunol., Volume 15 - 2024 Oct 11; DOI: 10.3389/fimmu.2024.1439413
Theodosiou T, Vrettos K, Baltsavia I, Baltoumas F, Papanikolaou N, Antonakis AΝ, Mossialos D, Ouzounis CA, Promponas VJ, Karaglani M, Chatzaki E, Brandau S, Pavlopoulos GA, Andreakos E, Iliopoulos I. BioTextQuest v2.0: An evolved tool for biomedical literature mining and concept discovery. Comput Struct Biotechnol J. 2024 Aug 21;23:3247-3253. doi: 10.1016/j.csbj.2024.08.016
Lapuente-Santana Ó, Sturm G, Kant J, Ausserhofer M, Zackl C, Zopoglou M, McGranahan N, Rieder D, Trajanoski Z, da Cunha Carvalho de Miranda NF, Eduati F, Finotello F. Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion. iScience. 2024 Jul 15;27(8):110529. DOI: 10.1016/j.isci.2024.110529
Pettinella F, Mariotti B, Lattanzi C, Bruderek K, Donini M, Costa S, Marini O, Iannoto O, Gasperini S, Caveggion E, Castellucci M, Calzetti F, Bianchetto-Aguilera F, Gardiman E, Giani M, Dusi S, Cantini M, Vassanelli A, Pavone D, Milella M, Pilotto S, Biondani P, Höing B, Schleupner MC, Hussain T, Hadaschik B, Kaspar C, Visco C, Tecchio C, Koenderman L, Bazzoni F, Tamassia N, Brandau S, Cassatella MA, Scapini P. Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors. Cell Reports Medicine, Volume 0, Issue 0, 101380. Jan 18, 2024; DOI: 10.1016/j.xcrm.2023.101380
Vanhaver C, Aboubakar Nana F, Delhez N, Luyckx M, Hirsch T, Bayard A, Houbion C, Dauguet N, Brochier A, van der Bruggen P, Bruger AM. Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype. Life Science Alliance. Nov 2023, 7 (1) e202302332; DOI: 10.26508/lsa.202302332
Domínguez-Andrés J, Reinecke H, Sohrabi Y. The immune hunger games: the effects of fasting on monocytes. Cell Mol Immunol. 2023 May 10. DOI: 10.1038/s41423-023-01033-w
Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, Brandau S. N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev. 2023 Mar;314(1):250-279. DOI: 10.1111/imr.13176
van Santvoort M, Lapuente-Santana Ó, Finotello F, van der Hoorn P, Eduati F. Mathematically mapping the network of cells in the tumor microenvironment. bioRxiv preprint. 2023 Feb 4. DOI: 10.1101/2023.02.03.526946
Acknowlegements
COST (European Cooperation in Science and Technology)
These publications are based upon work from the COST Action Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (Mye-InfoBank), CA20117, supported by COST (European Cooperation in Science and Technology).
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.